This study is testing a new wound dressing called Microlyte® DualGuard. It's designed to help heal partial-thickness donor site wounds (where skin is taken for a graft). Researchers want to see how safe and effective Microlyte® DualGuard is compared to a standard dressing, Allevyn® Foam. They will look at how well wounds close, if infections happen, and if there's pain, itching, or scarring. You can join if you are an adult (at least 22 years old) needing a skin graft from your thigh. The study will consider Microlyte® DualGuard successful if wounds close without drainage or needing a dressing, and if there are no serious side effects like infection. The current status of this study is unclear.

Study design

This is a multi-center, randomized, controlled, open-label study with about 53 participants. It compares Microlyte® DualGuard to a standard wound dressing.

What's involved

You will have clinic visits for up to 12 weeks. Researchers will assess wound healing, infection, pain, itching, and scarring during this time.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed from enrollment up to 84 days (12 weeks) to assess wound closure and adverse events.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.